Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Total Non-Current Liabilities (2024 - 2025)

Allarity Therapeutics' Total Non-Current Liabilities history spans 2 years, with the latest figure at $8.4 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 22.23% year-over-year to $8.4 million; the TTM value through Dec 2025 reached $8.4 million, down 22.23%, while the annual FY2025 figure was $8.4 million, 22.23% down from the prior year.
  • Total Non-Current Liabilities reached $8.4 million in Q4 2025 per ALLR's latest filing, down from $8.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $11.1 million in Q1 2025 to a low of $432000.0 in Q1 2024.